HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.

Abstract
Ninety-eight consecutive clinical isolates of Legionella pneumophila were tested for erythromycin, rifampicin and ciprofloxacin susceptibility. MICs, determined by agar dilution testing, were in the range 0.06-1 mg/L of erythromycin, 0.007-0.015 mg/L of rifampicin and 0.015-0.03 mg/L of ciprofloxacin. No resistance against the antibiotics tested was detected. It is thus likely that therapeutic failures in legionnaires' disease are not related to the emergence of resistance against commonly used antimicrobial agents.
AuthorsC Onody, P Matsiota-Bernard, C Nauciel
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 39 Issue 6 Pg. 815-6 (Jun 1997) ISSN: 0305-7453 [Print] England
PMID9222053 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antibiotics, Antitubercular
  • Ciprofloxacin
  • Erythromycin
  • Rifampin
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Anti-Infective Agents (pharmacology)
  • Antibiotics, Antitubercular (pharmacology)
  • Ciprofloxacin (pharmacology)
  • Drug Resistance, Microbial (physiology)
  • Erythromycin (pharmacology)
  • Legionella pneumophila (drug effects, metabolism)
  • Microbial Sensitivity Tests
  • Rifampin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: